Association of GLP-1 Receptor Agonists Versus Bariatric Surgery with Outcomes in Obese Patients with Hypertrophic Cardiomyopathy: A Multicenter Propensity-Matched Analysis academic.oup.com/ehjqcco/art…
Low Burden Transthyretin Cardiac Amyloidosis on Cardiac Magnetic Resonance: Comprehensive Phenotyping and Distinction from Hypertrophic Phenocopies academic.oup.com/ehjimp/arti…
❤️ 🧲CMR T2 mapping predicts survival in AL amyloidosis—even after strong treatment response. Myocardial edema flags hidden risk beyond biomarkers.
pdf 👉 journalofcmr.com/article/S10…
Dr. Yining Wang explains below 👇
#WhyCMR
The authors present the largest series of #TTVR after T-TEER with electrosurgical leaflet modification in a subset of patients. At 30 days, TR severity was markedly reduced, and substantial symptom alleviation occurred. jacc.org/doi/10.1016/j.jcin.…#JACCINT#vhdTR#TEER@jtsaxon
Women with chronic coronary artery disease: long-term outcomes after percutaneous coronary intervention vs coronary artery bypass grafting academic.oup.com/eurheartj/a…
Relative efficacy of tafamidis, acoramidis, patisiran and vutrisiran in patients with transthyretin cardiac amyloidosis: a network meta-analysis academic.oup.com/ehjopen/art…
Today, I had the pleasure of discussing atrial fibrillation in patients with hypertrophic cardiomyopathy and cardiac amyloidosis. I would like to thank my mentor for this opportunity and for his continued support. @CrottiLia
Transthyretin amyloid cardiomyopathy: natural history and treatment response assessed by cardiovascular magnetic resonance academic.oup.com/eurheartj/a…
We celebrate @michetomaselli who succesfully defended his PhD thesis about the advanced assessment of patients with secondary TR. Fantastic redult of 3 years of hard work